Discover
GRI
GRI Bio, Inc.
1.78
1 x 2.22
1 x 2.28
bid
ask
+
0.03
1.71%
1 @ 06:29 AM
1.90 +0.12 (6.74%)
| Ytd | -74.28% | |
| 1y | -95.36% |
1.70
day range
1.84
1.70
52 week range
80.36
| Open | 1.75 | Prev Close | 1.75 | Low | 1.70 | High | 1.84 | Mkt Cap | 3.15M |
| Vol | 45.94K | Avg Vol | 107.52K | EPS | 38.89 | P/E | 0.05 | Forward P/E | -0.29 |
| Beta | N/A | Short Ratio | 0.10 | Inst. Own | 4.71% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 2.15 | 200-d Avg | 18.91 | 1yr Est | 11.50 |
GRI News
benzinga.com
GRI Bio Says FDA Grants Orphan Drug Designation To GRI-0621 For Treatment Of Idiopathic Pulmonary Fi
Designation highlights significant regulatory milestone and provides a potential pathway to seven ye
benzinga.com
Dell Technologies To Gain Nearly 79%? Here Are 10 Analyst Calls Investors Should Know
Wall Street analysts updated views on notable stocks. See changes on analyst ratings page. Price tar
benzinga.com
Ascendiant Capital Maintains Buy on GRI Bio, Lowers Price Target to $32
Ascendiant Capital analyst Edward Woo maintains GRI Bio (NASDAQ:GRI) with a Buy and lowers the pr